Last reviewed · How we verify
NCT06635317
Efficacy of Aspirin in Preventing Venous Thromboembolism
Phase 4 trial testing Aspirin in Venous Thromboembolism (VTE) in 60 participants. Completed in 28 February 2023.
24 October 2022
Quick facts
| Lead sponsor | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 24 April 2022 |
| Primary completion | 24 October 2022 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Aspirin — full drug profile →
- enoxaparin — full drug profile →
Conditions studied
- Venous Thromboembolism (VTE) — all drugs for Venous Thromboembolism (VTE) →
- Total Joint Arthroplasty — all drugs for Total Joint Arthroplasty →
- Total Hip Arthroplasty (THA) — all drugs for Total Hip Arthroplasty (THA) →
Sponsor
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Who can join
Eligibility, any sex, with Venous Thromboembolism (VTE) or Total Joint Arthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Efficacy of aspirin and enoxaparin in preventing venous tromboembolism was compared after total knee or hip arthroplasty.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of Aspirin in Preventing Venous Thromboembolism in Total Knee and Hip Joint Replacement.
Campos-Flores D, Mercado-Arce A, Gómez-González A, Flores-Rascón J, et al · · 2024 · PMID 39720380 · DOI 10.7759/cureus.74347
Verify or expand the search:
- PubMed search for NCT06635317
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aspirin
Trials testing the same drug.
- NCT07525635 — Aspirin Dosing in Pregnancy · EARLY_PHASE1 · not yet recruiting
- NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
- NCT07373756 — Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk · Phase 4 · not yet recruiting
- NCT07180472 — Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol · Phase 4 · not yet recruiting
- NCT06638151 — Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) · Phase 2 · recruiting
Other recruiting trials for Venous Thromboembolism (VTE)
Currently open trials in the same condition.
- NCT07310693 — External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients · recruiting
- NCT07015905 — REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults · Phase 3 · recruiting
- NCT06958588 — Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis · Phase 4 · recruiting
- NCT06845423 — Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk · Phase 4 · recruiting
- NCT06731673 — Heat Shock Protein 47 in Thrombosis · recruiting
Other Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado trials
Trials by the same sponsor.
- NCT04399746 — Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 · NA · completed
- NCT06231459 — Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia · Phase 4 · completed
- NCT03601624 — Pomalidomide/Cyclophosphamide/Dexamethasone in Relapse Refractory Myeloma: Safety Profile in Mexicans · Phase 2 · unknown
- NCT05306002 — Nutritional Intervention and DNA Damage of Patients With HBOC · NA · completed
- NCT03701425 — Impact of Interventions With a Diet and Exercise on the Cardio-metabolic Status in Multi-risk Population · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06635317 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06635317.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing